Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Nuvation Bio Inc. (NUVB) vs Vericel Corporation (VCEL)

Nuvation Bio Inc. and Vericel Corporation are both Biotechnology companies. Nuvation Bio Inc. and Vericel Corporation are of similar size ($2.0B and $2.0B). Nuvation Bio Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 82.6×. Nuvation Bio Inc. grew revenue faster over the last twelve months: 1,083.6% against 23.0%. Vericel Corporation has the higher net margin (7.91% vs −88.2%) and the higher return on invested capital (5.49% vs 0.00%). Across the 18 metrics below, Vericel Corporation leads on 14 and Nuvation Bio Inc. on 4.

Valuation

Metric NUVB VCEL Biotechnology median
P/E n/m 82.63 7.88
P/S 11.78 6.61 11.47
P/B 7.89 5.47 2.52
Price to free cash flow n/m 32.85 21.16
EV/EBITDA n/m 62.29 0.74
EV/Sales 9.36 6.36 10.73
Earnings yield (7.57%) 1.21% (28.84%)
Free cash flow yield (6.04%) 3.04% (23.03%)

Profitability

Metric NUVB VCEL Biotechnology median
Gross margin 88.18% 74.56% 65.16%
Operating margin (81.00%) 5.95% 0.00%
Net margin (88.19%) 7.91% 0.00%
Free cash flow margin (71.17%) 20.13% 0.00%
Return on equity (47.81%) 7.16% (57.72%)
Return on assets (21.53%) 5.16% (49.22%)
Return on invested capital 0.00% 5.49% 0.00%

Growth

Metric NUVB VCEL Biotechnology median
Revenue growth (TTM) 1,083.56% 22.95% 5.64%
EPS growth (last fiscal year) 71.56% 60.00% —
Revenue growth, 5-year CAGR — 17.34% 8.40%
Net income growth, 5-year CAGR 0.00% 41.97% 0.00%

Health

Metric NUVB VCEL Biotechnology median
Debt to equity 0.98 0.00 0.00
Current ratio 8.37 5.04 4.73
Net debt to EBITDA 2.26 (6.08) 0.96

Dividend

Metric NUVB VCEL Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NUVB VCEL Biotechnology median
Market cap 2.02b 2.03b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack